Results 141 to 150 of about 13,488 (162)

Bispecific Aptamer-Based Recognition-then-Conjugation Strategy for PD1/PDL1 Axis Blockade and Enhanced Immunotherapy

ACS Nano, 2022
, Xiaohong Fang, Mao Ye
exaly  

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma

Journal of Hepatology, 2022
Chuan-Yuan Wei, Meng-Xuan Zhu, Xiao-Yong Huang   +2 more
exaly  

Cisplatin nanoparticles possess stronger anti-tumor synergy with PD1/PD-L1 inhibitors than the parental drug

Acta Biomaterialia, 2021
Na Shen, Xuefei Zhang, Zhaohui Tang
exaly  

A Pd1–Ps–P1 Feedback Loop Controls Pubescence Density in Soybean

Molecular Plant, 2020
Shulin Liu, Zhi Liu, Zongbiao Duan
exaly  

Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations

International Journal of Molecular Sciences, 2021
Nicolas Piton, Mathieu Salaun, Luc Thiberville   +2 more
exaly  

BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse

Cell Stem Cell, 2020
Lingfei Jia, Cun-Yu Wang
exaly  

The impact of corticosteroid use during anti-PD1 treatment

Journal of Oncology Pharmacy Practice, 2020
Eva Y Pan
exaly